EU fines Teva for blocking cheaper generic drugs - Israel News, Ynetnews

   Israel News

Israel News
World News
Israel Opinion
Israel Business
Israel Culture
Israel Travel
Breaking News


EU fines Teva for blocking cheaper generic drugs

Published: 07.09.14, 15:38 / Israel News

European Union antitrust regulators fined French drugmaker Servier, Israel's Teva and four others a total of 428 million euros ($583 million) on Wednesday for blocking cheaper generic medicine.


The sanctions are the third by the European Commission against so-called pay-for-delay deals in the pharmaceutical industry, where brand-name drugmakers pay cheaper non-brand generics firms to hold back from launching rival medicines.


"Servier had a strategy to systematically buy out any competitive threats to make sure that they stayed out of the market. Such behaviour is clearly anti-competitive and abusive," European Competition Commissioner Joaquin Almunia said in a statement.


  PrintPrint  Send to friendSend to friend   
Tag with Bookmark to


RSS RSS | About | Contact Us | Privacy Policy | Terms of use | Advertise with us | Site Map

Site developed by  YIT Advanced Technology Solutions